News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Martin Daniel C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2023 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,603 shares
@ $21.2413, valued at
$34k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,146 shares
@ $9.05, valued at
$10.4k
|
|
| 01/20/2022 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 13,667 shares
@ $0
Granted 54,667 options to buy
@ $8.27, valued at
$452.1k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
3
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 3 on Deciphera Pharmaceuticals, Inc. |
| 01/24/2020 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 26,999 shares
@ $36.1, valued at
$974.7k
Sold 26,999 shares
@ $67.1769, valued at
$1.8M
Converted 26,999 options to buy
@ $36.1, valued at
$974.7k
|
|
| 09/23/2019 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 3,000 shares
@ $35.5627, valued at
$106.7k
|
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2018 |
4
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 90,000 options to buy
@ $36.1, valued at
$3.2M
|
|
| 09/20/2018 |
3
| Martin Daniel C. (Chief Commercial Officer) has filed a Form 3 on Deciphera Pharmaceuticals, Inc. |
|
|